CUSIP: 72940R102
Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
974,481
-
Share change
-
+414,586
-
Total reported value
-
$3,593,480
-
Put/Call ratio
-
154%
-
Price per share
-
$3.71
-
Number of holders
-
21
-
Value change
-
+$1,533,821
-
Number of buys
-
11
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP 72940R102?
CUSIP 72940R102 identifies PSTI - PLURISTEM THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2014
-
Previous quarter:
Q4 2013
Recent filing periods for CUSIP 72940R102:
Institutional Holders of PLURISTEM THERAPEUTICS INC - COM (PSTI) as of Q1 2014
As of 31 Mar 2014,
PLURISTEM THERAPEUTICS INC - COM (PSTI) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
974,481 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, JPMORGAN CHASE & CO, UBS AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Verity Asset Management, Inc., OPPENHEIMER & CO INC, Psagot Investment House Ltd., VAN ECK ASSOCIATES CORP, and JANE STREET GROUP, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.